ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?

Tendera, Michal; Syzdól, Marcin; Parma, Zofia

Tendera, Michal; Syzdól, Marcin; Parma, Zofia.

Affiliation

Tendera M; Division of Cardiology, Medical University of Silesia, Katowice, Poland. michal.tendera@gcm.pl

Cardiol J ; 19(1): 4-10, 2012.

Article in En | MEDLINE | ID: mdl-22298161

Subject(s)

Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Stroke/prevention & control; Anticoagulants/adverse effects; Atrial Fibrillation/complications; Benzimidazoles/therapeutic use; Clinical Trials as Topic; Dabigatran; Evidence-Based Medicine; Hemorrhage/chemically induced; Humans; Morpholines/therapeutic use; Patient Selection; Pyrazoles/therapeutic use; Pyridones/therapeutic use; Risk Assessment; Rivaroxaban; Stroke/etiology; Thiophenes/therapeutic use; Time Factors; Treatment Outcome; Warfarin/therapeutic use; beta-Alanine/analogs & derivatives; beta-Alanine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Anticoagulants Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cardiol J Year: 2012 Type: Article Affiliation country: Poland

Search on Google

XML

PubMed Links